Navigation Links
New Imaging Technology Helps in Diagnosing Parkinson's Disease
Date:9/28/2011

WINFIELD, Ill., Sept. 28, 2011 /PRNewswire-USNewswire/ -- Fifty thousand to 60,000 new cases of Parkinson's disease are diagnosed in the United States each year(i). Central DuPage Hospital (CDH) in Winfield, Ill., is among the first medical centers in North America to be using a new technology called DaTscan, an imaging tool that aids doctors in diagnosing patients who demonstrate Parkinsonian symptoms, like Parkinson's disease. DaTscan is the first and only objective diagnostic tool approved by the FDA to be used for differentiating Parkinsonian syndromes from other movement disorders.

(Logo: http://photos.prnewswire.com/prnh/20100715/DC35744LOGO)

"DaTscan serves as a supplemental resource to a doctor's clinical evaluation of Parkinsonism and truly helps with patients whose symptoms are inconclusive or who have a confusing diagnosis," said Michael Rezak, M.D., Ph.D., director, Movement Disorders Center at CDH. "With DaTscan, doctors can now diagnose Parkinsonism earlier and initiate appropriate treatments sooner."

DaTscan, developed by GE Healthcare, is an imaging test used to assess dopamine levels in the brain. Dopamine affects the ability of the brain to control movement and other muscle functions. The imaging drug is injected into a patient's bloodstream and labels the dopamine neurons. A single photon emission computed tomography (SPECT) scanner is then used to measure the amount and location of the drug in the brain. Patients with Parkinson's disease, or other Parkinsonian syndromes, including multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) among others, will have scans that show low levels of dopamine.

Parkinson's disease is the second most common neurodegenerative disorder. Although DaTscan cannot differentiate between the different Parkinsonian syndromes, it can help rule out other movement disorders, like essential tremor.

"DaTscan is a great addition to our Neuroscience Institute here at CDH. Overall, doctors in all medical centers carrying this tool can have more confidence in diagnosing patients with Parkinson's disease and other movement disorders," said Rezak.

For more information, contact CDH's Neuroscience Institute at 630-933-4056.

About Central DuPage Hospital

Central DuPage Hospital (CDH) is a nationally recognized 313-bed facility located in Winfield, Ill., a suburb west of Chicago. CDH is a leading center for medical technology, one of the busiest surgical hospitals in Illinois and has achieved Magnet® recognition for excellence in nursing services.

For the last five consecutive years, Thomson Reuters has listed CDH as a 100 Top Hospital in the U.S. CDH is affiliated with other healthcare leaders, including regionally known Children's Memorial Hospital for pediatric care and nationally known Cleveland Clinic for cardiac surgery.

Central DuPage Hospital is an interdependent network of healthcare organizations and services, including convenient care centers, occupational health services, home health and hospice care. For more information or to find a doctor on the medical staff of CDH, visit www.cdh.org or call 630-933-4234/ TTY 630-933-4833 for the hearing impaired.

(i) "Parkinson's Disease (PD) Overview." National Parkinson Foundation. Website: http://www.parkinson.org/parkinson-s-disease.aspx. Accessed on Sept. 13, 2011.  


'/>"/>
SOURCE Central DuPage Hospital
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ziehm Imaging Gets a New Sister Company
2. Vista Imaging Services, Inc. Supplies New C-Arm Inventory and Highly Qualified Professional Radiology Technologists to the Texas Institute for Medical Education (TIME) and Medical Education & Research Institute of Nevada (MERIN)
3. Medical Imaging of Fredericksburg Highlighted in Imaging Economics Best of 2011 Radiology Facilities Issue
4. vRad Acquires Diagnostic Imaging Inc. and Merges On-Site Radiology Practice into Growing National Network
5. Elbit Imaging Ltd. Announces Standard & Poors Maalot Changes Rating of Company and its Subsidiary Notes
6. Elbit Imaging Announces Availability of Investor Relations Presentation - Analysis Sources and Uses
7. Elbit Imaging Ltd. Announces Second Quarter Results for 2011
8. Elbit Imaging Ltd. Announces Interest Rate for the Next Interest Period for Series B Notes
9. Pathologists Gather to Focus on Advances in Molecular Testing, Digital Imaging, and Biospecimens
10. Strategic Assessments of Leading North American Diagnostic Imaging Market Players
11. MarketsandMarkets: "Radiopharmaceuticals for Therapy and PET/SPECT Imaging" Market to reach $4,734 Million by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... Sept. 22, 2017 AVACEN Medical (AVACEN) announced ... now successfully helping those with the widespread pain associated ... diagnosed Amanda in Essex, England ... my hair, experiencing no sleep at all, tremendous pain, ... I cannot recommend [the AVACEN 100] enough, how this ...
(Date:9/19/2017)... LOUISVILLE, Ky. , Sept. 19, 2017   ZirMed ... and predictive analytics, today announced that it has been ranked ... the Black Book™ Rankings 2017 User Survey. ZirMed ... software solution for large hospitals and medical centers over 200 ... in Black Book,s healthcare technology user survey history. ...
(Date:9/18/2017)... 2017 EpiVax, Inc. ("EpiVax") a ... immune engineering, today announced a new NIH-funded ... ... and presents a challenge for traditional flu ... be effective. Using state-of-the-art bioinformatics and molecular modeling methods, ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical ... Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. ... honor of Morris F. Collen, a pioneer in the field of medical informatics, this ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... ... , ... HMP , a leader in healthcare events and education, today announced ... Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie ... competition recognizes editorial and design excellence across a range of sectors. This year’s program ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
Breaking Medicine News(10 mins):